Coinbase Adds Bio Protocol (BIO) and Euler (EUL) to Listing Roadmap
Coinbase, one of the top US crypto exchanges, has recently announced the addition of two altcoins to its listing roadmap, causing a surge in the prices of the respective digital assets.
The exchange revealed that Bio Protocol (BIO), a project related to biotechnology, and Euler (EUL), a decentralized finance (DeFi) lending platform, are under consideration to be made available for trading by Coinbase customers in the near future. This move is part of Coinbase’s efforts to increase transparency and prevent investors from front-running new trading support announcements.
Following the news, the price of BIO has experienced a 9.1% increase, reaching $0.06963 at the time of writing. However, it is currently trading lower than its daily high of $0.07799.
On the other hand, EUL saw a significant price jump from a recent low of $12.63 to $14.12 after the Coinbase announcement. As of now, EUL has retraced to the $13 range.
BIO serves as the native token of the Bio Protocol platform, which aims to facilitate biotechnology advancements by allowing global communities of patients, scientists, and biotech professionals to collectively fund, develop, and own tokenized biotech projects and intellectual property.
Similarly, EUL functions as the native governance token of the Euler protocol, which strives to simplify lending and borrowing processes in DeFi, making them more efficient and versatile. Users are also granted the freedom to explore new opportunities within the DeFi space.
Stay Updated with The Daily Hodl
For more crypto news and updates, follow The Daily Hodl on X, Facebook, and Telegram. Subscribe to receive email alerts directly to your inbox and stay informed about the latest price actions and developments in the crypto market.
Don’t miss out on the latest updates in the crypto world!
Check out The Daily Hodl Mix for a curated selection of crypto news and insights.
Image Credit: Midjourney